4//SEC Filing
Sobel Alan D. 4
Accession 0001104659-23-126432
CIK 0001175151other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 4:35 PM ET
Size
9.2 KB
Accession
0001104659-23-126432
Insider Transaction Report
Form 4
Sobel Alan D.
Director
Transactions
- Purchase
Common Stock
2023-12-13$1.33/sh+22,557$30,001→ 101,857 total - Purchase
Common Stock Warrant (Right to Buy)
2023-12-13+7,894→ 7,894 totalExercise: $2.00From: 2023-12-13Exp: 2028-12-13→ Common Stock (7,894 underlying)
Holdings
- 2,000(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]These securities were purchased by the reporting person in the registered direct offering of CytoSorbents Corporation (the "Company"), which closed on December 13, 2023. In the offering, each share of common stock, par value $0.001 per share (the "Common Stock") of the Company was purchased together with an accompanying warrant to purchase up to 0.35 shares of Common Stock, at a combined offering price of $1.33 per share of Common Stock and accompanying warrant.
- [F2]Includes (i) the following restricted stock units ("RSUs") that will be settled into Common Stock upon vesting upon a "Change in Control" of the Company, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan"): (a) 3,300 RSUs granted on March 15, 2018, (b) 6,000 RSUs granted on February 24, 2017, (c) 5,000 RSUs granted on June 7, 2016, and (d) 55,000 RSUs granted on April 8, 2015 and (ii) 32,557 shares of Common Stock owned directly by the reporting person.
- [F3]These shares are held in the Bernard Sobel Revocable Trust (the "Trust"), for which the reporting person is a trustee and a named beneficiary. Accordingly, the reporting person may be deemed the beneficial owner of the shares held in the Trust.
Documents
Issuer
Cytosorbents Corp
CIK 0001175151
Entity typeother
Related Parties
1- filerCIK 0001639386
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 4:35 PM ET
- Size
- 9.2 KB